KINSLEY POPPA: Open Payments
NPI 1275242307 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 15 payments from 6 companies in 2025. Trend: 2023 $19 · 2024 $104 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $209 |
| ViiV Healthcare Company | 2 | $127 |
| Insmed, Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $19 |
Products named: CABENUVA, Biktarvy, Arikayce, NUZYRA, LM Undivided, PREVYMIS, ZERBAXA.
Industry payments across LA — which companies pay providers there.
